Pharmaceuticals

AstraZeneca announced it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical trial that tested the safety and effectiveness of the blood thinner ticagrelor (Brilinta)....

Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and Immunology (LIAI), are one step closer to the goal of developing the world’s first T-cel...

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t respond to medication, suggests preliminary research presented at the 56th annual me...

June 3, 2014 — The U.S. Food and Drug Administration (FDA) announced it approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death and need for procedures to restore the blood flow to the heart in patie...

Professors Updated Information Aspirin Heart Attack Prevention
The first researcher in the world to discover that aspirin prevents a first attack, Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor...
heart attack, JAMA, American Medical Association, acute coronary syndrome
In patients who experienced an acute coronary syndrome (ACS) event, use of the drug darapladib to inhibit the enzyme lipoprotein-associated phospholipase A2...
Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced results from the X-VeRT trial, demonstrating once-...
August 28, 2014 — Renal artery stenting to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical...
Zontivity (vorapaxar) tablets reduce the risk of heart attack, stroke, cardiovascular death and need for procedures to restore the blood
Atherotech Diagnostics Lab offers warfarin sensitivity, Plavix sensitivity and thrombophilia risk tests. The warfarin and Plavix...
Liptruzet (pronounced LIP-true-zett) contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin, currently one...
The U.S. Food and Drug Administration approved Kcentra (prothrombin complex concentrate, human) for the urgent reversal of vitamin K...

Articles

August 28, 2014 — Renal artery stenting to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical...
U.S. Department of Justice Close Investigation PLATO Clinical Trial Ticagrelor
AstraZeneca announced it has received confirmation from the United States Department of Justice that it is closing its investigation into PLATO, a clinical...
Clinical Study Heart Vaccine Pharmaceutical
Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and...
July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t...

Video Center

As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
1 week 5 days ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
7 weeks 3 days ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
9 weeks 5 days ago
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
This webinar demonstrates the Centricity Cardio Enterprise Solution (CCE), a solution that can help cardiology departments and hospital administrators to...

Comparison Charts

Sorry there is no data available